XBI — State Street SPDR S&P Biotech ETF, BUY 63/100 signal

State Street SPDR S&P Biotech ETF
$156.2 ▼ -0.40%
63/100
BUY
5-factor composite · bullish read
📅 Earnings imminent implied move, history & analyst posture Pre-earnings brief →
Technical (35%)63
Momentum (24%)56
Fundamental (0%) · not in composite50
Options (13%)41
Microstructure (28%)61
✓ Verified Track Record
42% win rate across 3,959 resolved signals — every QuantLogix signal is logged at issuance and graded against live market outcomes.

QuantLogix's 5-factor engine currently reads State Street SPDR S&P Biotech ETF (XBI) as a buy at 63/100 — a bullish setup. Technical is the strongest leg at 63/100, while options lags at 41/100.

Live 5-factor quant signal — technical, momentum, fundamental, options, and microstructure — recomputed every few minutes. Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. See the verified track record → · Browse all signal scorecards →

Link copied